Dosing initiated in transmolecular’s phase 1/2 clinical trial for intravenous administration of 131iodine-tm601 in patients with recurrent malignant glioma
admin (Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Posted in Cancer |